Evidence map›Paper›PMID 38536908›Full record

ArticleScience advances2024

TisB protein is the single molecular determinant underlying multiple downstream effects of ofloxacin in

Julien Cayron, Thierry Oms, Tatjana Schlechtweg, Safia Zedek, Laurence Van Melderen

Open access · goldAbstract read
In one paragraph

Article in Science advances, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
3.7field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 22 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Julien CayronBacterial Genetics and Physiology, Faculté des Sciences, Université Libre de Bruxelles (ULB), 6041 Gosselies, Belgium.ORCID 0000-0002-6607-311X
Thierry OmsBacterial Genetics and Physiology, Faculté des Sciences, Université Libre de Bruxelles (ULB), 6041 Gosselies, Belgium.ORCID 0000-0001-8878-8530
Tatjana SchlechtwegBacterial Genetics and Physiology, Faculté des Sciences, Université Libre de Bruxelles (ULB), 6041 Gosselies, Belgium.ORCID 0000-0001-8430-3954
Safia ZedekBacterial Genetics and Physiology, Faculté des Sciences, Université Libre de Bruxelles (ULB), 6041 Gosselies, Belgium.
Laurence Van MelderenBacterial Genetics and Physiology, Faculté des Sciences, Université Libre de Bruxelles (ULB), 6041 Gosselies, Belgium.ORCID 0000-0002-7778-1736
Université Libre de Bruxelles · BE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Bactericidal antibiotics can cause metabolic perturbations that contribute to antibiotic-induced lethality. The molecular mechanism underlying these downstream effects remains unknown. Here, we show that ofloxacin, a fluoroquinolone that poisons DNA gyrase, induces a cascade of metabolic changes that are dependent on an active SOS response. We identified the SOS-regulated TisB protein as the unique molecular determinant responsible for cytoplasmic condensation, proton motive force dissipation, loss of pH homeostasis, and H

Indexed as

Escherichia coliEscherichia coli ProteinsAnti-Bacterial AgentsDNA GyraseHydrogen PeroxideOfloxacinAnti-Bacterial AgentsDNA GyraseEscherichia coli ProteinsHydrogen PeroxideOfloxacin

Identifiers

PMID38536908
PMCPMC10971487
OpenAlexW4393245982

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.